N-(2,2-Dimethyl-6-morpholino-1-oxo-2,3-dihydro-1H-inden-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

ID: ALA4557715

PubChem CID: 129284027

Max Phase: Preclinical

Molecular Formula: C22H23N5O3

Molecular Weight: 405.46

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O

Standard InChI:  InChI=1S/C22H23N5O3/c1-22(2)12-14-10-17(18(11-15(14)19(22)28)26-6-8-30-9-7-26)25-21(29)16-13-24-27-5-3-4-23-20(16)27/h3-5,10-11,13H,6-9,12H2,1-2H3,(H,25,29)

Standard InChI Key:  GZDUDIFYOWVYPG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   15.3739   -4.0034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0838   -3.5989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3786   -3.1864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0564   -4.4229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7660   -4.0135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7632   -3.1908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0546   -2.7856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3483   -4.0140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3495   -3.1929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5690   -2.9380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5670   -4.2665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4721   -4.4202    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4714   -5.2383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1757   -5.6457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8851   -5.2395    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.8858   -4.4214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1770   -4.0094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4693   -2.7796    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4663   -1.9624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1724   -1.5511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7570   -1.5565    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.0504   -0.5646    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2518   -0.7377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4617   -1.2709    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.9150   -1.8782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1680   -2.6533    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.9673   -2.8221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5132   -2.2098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2573   -1.4371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3132   -5.0432    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  8  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  9  1  0
  8  9  2  0
  9 10  1  0
 10  2  1  0
  2 11  1  0
 11  8  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
  5 12  1  0
  6 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 20 25  2  0
 24 22  1  0
 22 23  2  0
 23 20  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 11 30  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4557715

    ---

Associated Targets(Human)

IRAK4 Tchem Interleukin-1 receptor-associated kinase 4 (5917 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.46Molecular Weight (Monoisotopic): 405.1801AlogP: 2.58#Rotatable Bonds: 3
Polar Surface Area: 88.83Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.49CX Basic pKa: 0.43CX LogP: 2.60CX LogD: 2.60
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.72Np Likeness Score: -1.47

References

1. Rajapaksa NS, Gobbi A, Drobnick J, Do S, Kolesnikov A, Liang J, Chen Y, Sujatha-Bhaskar S, Huang Z, Brightbill H, Francis R, Yu C, Choo EF, DeMent K, Ran Y, An L, Emson C, Maher J, Wai J, McKenzie BS, Lupardus PJ, Zarrin AA, Kiefer JR, Bryan MC..  (2020)  Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo Activity.,  11  (3): [PMID:32184965] [10.1021/acsmedchemlett.9b00380]

Source